Columbia Research Enhanced Core ETF (RECS)
| Assets | $4.55B |
| Expense Ratio | 0.15% |
| PE Ratio | 21.91 |
| Shares Out | 110.88M |
| Dividend (ttm) | $0.38 |
| Dividend Yield | 0.91% |
| Ex-Dividend Date | Dec 18, 2024 |
| Payout Ratio | 20.09% |
| 1-Year Return | +13.85% |
| Volume | 375,616 |
| Open | 41.35 |
| Previous Close | 41.30 |
| Day's Range | 41.33 - 41.54 |
| 52-Week Low | 28.64 |
| 52-Week High | 41.64 |
| Beta | 0.90 |
| Holdings | 380 |
| Inception Date | Sep 25, 2019 |
About RECS
Fund Home PageThe Columbia Research Enhanced Core ETF (RECS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000. The index uses multifactor selection and market cap weighting. RECS was launched on Sep 25, 2019 and is issued by Columbia Threadneedle.
Top 10 Holdings
41.04% of assets| Name | Symbol | Weight |
|---|---|---|
| NVIDIA Corporation | NVDA | 11.84% |
| Apple Inc. | AAPL | 11.68% |
| JPMorgan Chase & Co. | JPM | 3.67% |
| Alphabet Inc. | GOOG | 3.07% |
| Meta Platforms, Inc. | META | 2.86% |
| Visa Inc. | V | 2.48% |
| Alphabet, Inc. | GOOGL | 1.60% |
| The TJX Companies, Inc. | TJX | 1.33% |
| Booking Holdings Inc. | BKNG | 1.30% |
| Pfizer Inc. | PFE | 1.21% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 18, 2024 | $0.37827 | Dec 26, 2024 |
| Dec 18, 2023 | $0.27653 | Dec 26, 2023 |
| Dec 19, 2022 | $0.32054 | Dec 27, 2022 |
| Dec 20, 2021 | $5.55569 | Dec 27, 2021 |
| Dec 18, 2020 | $0.26779 | Dec 28, 2020 |
| Dec 20, 2019 | $0.1062 | Dec 26, 2019 |
News
RECS: The High Achiever Deserves An Upgrade
RECS has an index-based strategy designed to benefit from the worthiest names in the Russell 1000 index. In April 2022, I assigned a Hold rating to it owing to the small AUM and unideal liquidity. The...
RECS: Among The Best Quality ETFs
Columbia Research Enhanced Core ETF selects stocks in the Russell 1000 based on quality and value, keeping the same sector breakdown as the parent index. The RECS ETF has outperformed the Russell 1000...
Columbia Research Enhanced Core ETF (RECS) Celebrates Five-Year Anniversary, $1B AUM Milestone
BOSTON--(BUSINESS WIRE)--Columbia Threadneedle Investments recently celebrated the five-year anniversary of its equity exchange-traded fund (ETF)—the Columbia Research Enhanced Core ETF (NYSE Arca: RE...
Columbia Research Enhanced Core ETF (RECS) and Columbia Research Enhanced Value ETF (REVS) Celebrate Three-Year Milestone
BOSTON--(BUSINESS WIRE)---- $RECS--Columbia Threadneedle Investments celebrated the three-year anniversary of two of its strategic beta equity exchange-traded funds (ETFs), the Columbia Research Enhan...
RECS: Powerful Strategy Begetting Alpha, Though Size, Liquidity Amongst Vulnerabilities
RECS is an around $31.5 million passively managed fund focused on delivering alpha by selecting the most promising stocks from the Russell 1000 index using a proprietary ranking system.
Growth Stocks Signaling Value Cycles
Since September 2020, value stocks finally have rallied as the Russell 1000 Value Index has outperformed the Russell 1000 Growth by almost 21%. When spreads narrowed from their highs, the value cycle ...
